quinta-feira, 12 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 12, 2026

Six Stocks That Could Soar in an Era of Regional Instability

View original at finance.yahoo.com
Six Stocks That Could Soar in an Era of Regional Instability The missile strikes on Feb. 28 changed the math for every commodity desk in the world……
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Oil price projection of $120 per barrel

    60% confidence
  • The U.S. has a 'virtually unlimited' supply of heavy weaponry

    60% confidence
  • A 'big wave' of attacks yet to come with a four-week window to finalize regime change

    60% confidence
  • Urea prices at New Orleans surged from $475 per ton to $520-$550 per ton in first week of conflict

    60% confidence
  • Over 200 vessels are stranded in Strait of Hormuz

    60% confidence
  • Plans to triple PAC-3 missile production to 2,000 units annually

    60% confidence
  • Warning of $150 per barrel oil if traffic through Strait of Hormuz doesn't recover by end of March

    60% confidence
  • Nitrogen demand expected to remain positive through spring 2026 application season fueled by high planted acres of corn in U.S.

    60% confidence

Data points we hold from this source

Lockheed Martin Corporation · net income5 USD
Lockheed Martin Corporation · capital expenditures2.5 USD
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,565 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Six Stocks That Could Soar in an Era of Regional Instability — Source | Via News | pt.VIA.NEWS